Despite what was said back in May, there is no more ‘month’. There is only the IND finish line. And then the clinical trials starting line. And the clinical trials finish line. I hope we continue to be in the race and finish in fine form. A long way to go.
And then there’s ‘AAAA prospect’ Excellagen. The wound healing season is upon us. Put Excellagen into the game, give it the damn ball and let’s see if all the hype is real.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links